Increased rates of HIV infection were seen among women using depot medroxyprogesterone acetate (Depo-Provera or DMPA), whereas other methods of contraception including oral contraceptive pills or norethisterone enanthate (Net-En, an injectable progestin steroid) did not, according to a new meta-analysis.
Depo-Provera May Hike HIV Risk in Women
